The Age of the Killer T-cells
November 11, 2019
It is well-known how important the immune system is in eradicating cancer. Immunotherapy has evolved and many approaches are being explored. Among these is the use of chimeric antigen receptor T-cell therapy. The process of generating cancer specific T-cell from each patient will be discussed. Current therapy approved will be discussed including those used in lymphoma and acute lymphoblast Leukemia. Ongoing research will be presented.
WHAT YOU'LL LEARN
- How CAR T-Cell specific for certain cancer are generated
- Review the clinical benefit of CAR T-cell
- Understanding the side effect of CAR T-cells therapy
- Discuss the future of CAR T-cell therapy
Anyone can attend the webinar from beginners to intermediate and advanced learners on the topic.
WHAT ARE THE BENEFITS
- Become familiar with components of the immune response and cancer cells
- Become familiar with future CAR T-cells therapy
- Become aware of the limitations of current CAR T-cells therapy
MEET THE INSTRUCTOR
Rafat Abonour, M.D.
Harry and Edith Gladstein Professor of Cancer Research
Professor of Medicine, Pathology and Laboratory Medicine
Director, Multiple Myeloma,Waldenstrom's Disease and Amyloidosis Program
Rafat Abonour, MD is Professor of medicine, pathology, and laboratory medicine at Indiana University where has worked since 1995. Dr Abonour earned his medical degree from the University of Damascus in Syria. He completed his residency in internal medicine and fellowship in hematology at the University of Wisconsin in Madison, Wisconsin.
Dr Abonour established and directs the multiple myeloma and plasma cell program at Indiana University. His clinical interests include novel therapies for multiple myeloma and hematopoietic stem cell processing, including gene therapy. Dr Abonour is principal or co-investigator of several completed and on-going clinical trials. . Dr Abonour has authored or coauthored numerous peer-reviewed manuscripts, book chapters, and review articles. His worked has been published in key medical research journals including Blood, New England Journal of Medicine and Nature Medicine.
Dr Abonour is a member of the Eastern Cooperative Group Data Monitoring Committee for Myeloma, the Scientific Research Committee at Indiana Cancer Center, and the Indiana University Executive Review Board. Dr Abonour has joined the International Myeloma Foundation in 2015 as their medical liaison to Europe. In addition, he is actively involved in a number of professional societies including the American Society of Hematology and the American Society of Clinical Oncology. He has lectured nationally and internationally and received numerous awards, including the Trustee Teaching Award from Indiana University and the Excellence in Cancer Care Award from the Indianapolis Leukemia and Lymphoma Society. Dr Abonour, M.D., received a Sagamore of the Wabash, the highest honor an Indiana governor can bestow in 2010.
EARN CEUsParticipants are eligible to receive CEUs upon attendance and successful completion of a web-based assessment within 30 days after the webinar. CEUs are not granted after the 30-day assessment deadline.
SCDM is authorized by IACET to offer 0.2 CEUs for this program.
|Group (max. 10 ppl.)||$960||$1,140|
Group Registration Policy: Any group registration allows up to 10 people to attend the webinar and to complete the webinar assessment. Credits will be granted on an individual basis upon successful completion of the assessment by the registered participants.
Refund Policy: Participants will receive a full refund if notice is provided in writing via post or email one week prior to the webinar date. If cancellation occurs within the week prior the webinar, participants will be allowed to apply 50% of the webinar fee to the next offering of the same webinar. No refunds will be offered after that time.
Click on the help button on the bottom right, select contact support and email the BlueSky team with any technical issues.
Otherwise e-mail directly to email@example.com or call +1-888-705-6002 for immediate help.
The SCDM Learning team is here to help. Contact us at firstname.lastname@example.org or call +32 232 024 87